Tonix sues Dr. Reddy's over generic TONMYA patent challenge
Tonix Pharmaceuticals filed a patent infringement complaint against Dr. Reddy's Laboratories in New Jersey federal court on November 13, 2026, triggering a potential 30-month stay on FDA approval of the generic.
SEC filing